Search Results for: stem cell banking

Cryogenics to stem cell banking: time for deposit?

liquid_nitrogen2011-12-300x2301

Is it worth it to do stem cell banking? When I was a kid I remember hearing about people having themselves frozen or even just their heads frozen shortly after death. The idea was to cheat mortality by preserving oneself or critical parts of oneself until some future date when scientists and doctors would have …

Cryogenics to stem cell banking: time for deposit? Read More »

2023 stem cell predictions grades reflect wild year for regenerative medicine

stem cell predictions

Every year I make stem cell and regenerative medicine predictions. Looking at my predictions for 2023, they reflect a wild year but in many ways a good one overall. Below I have graded my 2023 predictions. Overall, my crystal ball gave solid results. Some of the predictions have been condensed to keep things concise, but you …

2023 stem cell predictions grades reflect wild year for regenerative medicine Read More »

Weekly reads: embryonic stem cells, Parkinson’s, Alzheimer’s

Knoepfler lab stem cells

Early during my postdoc I was primarily interested in the role of Myc genes both in cancer and in stem cells, work that later included embryonic stem cells. These cells are often called ES cells. At first I first started studying N-Myc in neural stem cells using a conditional knockout approach. However, soon after I was …

Weekly reads: embryonic stem cells, Parkinson’s, Alzheimer’s Read More »

2023 stem cell & regenerative medicine predictions

stem cell predictions

Toward the end of each year, I make stem cell & regenerative medicine predictions for the coming year. It’s a fun tradition here on The Niche that goes way back. The stem cell field has changed dramatically as reflected in each year’s predictions. Here’s a list of past predictions with my grades of how they …

2023 stem cell & regenerative medicine predictions Read More »

16 predictions for stem cells & regenerative medicine in 2022

regenerative medicine, stem cells 2021

The last few years in the stem cell and regenerative medicine arena have been complicated in many ways. Variables like surging stem cell clinics and COVID have made predictions harder.  Even so, trying to make predictions is useful and it’s fun to go over past year’s predictions. You can see my scorecard on my 2021 …

16 predictions for stem cells & regenerative medicine in 2022 Read More »

Top stem cell stories of 2021: COVID, diabetes, human embryos, clinics in court

regenerative medicine, stem cells 2021

The past year was all over the place for the stem cell and regenerative medicine field. As you can see in my scoring of my 21 predictions for 2021, quite a few things were surprises in terms of what did and didn’t happen. Here’s an overview of the top stories of the year in our …

Top stem cell stories of 2021: COVID, diabetes, human embryos, clinics in court Read More »

Recommended reads: stem cell scientists, eggs from blood, Cryo-Cell

Nobel Laureate Shinya Yamanaka, the first to produce induced pluripotent stem cells

We’ll begin this week’s recommended reads with some news on two wonderful stem cell scientists. While there are thousands of stem cell scientists, some stand out for their especially creative work. News on stem cell scientists   Nobel laureate Yamanaka to retire as director of iPS cell center, Asahi Shimbun. Dr. Yamanaka will spend more time …

Recommended reads: stem cell scientists, eggs from blood, Cryo-Cell Read More »

2021 scorecard for stem cell stocks: REGN, VCEL, CCEL, LCTX did best

Mesoblast stock

A quick review of the publicly-traded stem cell stocks I’ve been following in 2021 finds mostly discouraging news, but a few firms relatively outperformed the other publically-traded biotechs. One had some great news today. In this post, I’m doing a brief overview of how things went this year in the regenerative medicine space. I’m going …

2021 scorecard for stem cell stocks: REGN, VCEL, CCEL, LCTX did best Read More »

Fact-checking stem cell therapy for autism: still a risky idea

Duke-Curemark-autism-study-pamphlet

The other day I gave a talk in part about stem cell hype and mentioned as an example how the idea of already doing stem cell therapy for autism seems so misguided to me now.  On the whole, in my view there are major downsides and risks for autistic kids whose parents are already having …

Fact-checking stem cell therapy for autism: still a risky idea Read More »